drugset / Trial / NCT02923583
Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is assess the pharmacokinetics and safety of M834 and Orencia ® following administration of a single-dose in healthy volunteers.
Timeline
- Start
- 2016-10
- Primary completion
- 2017-07-21
- Completion
- 2017-07-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Abatacept | Other / unclassified | — | — |
| Subject | M834 | Protein / enzyme biologic | — | — |
Indications
No indication recorded.